Vanda Pharmaceuticals IncNASDAQ:VNDA
- LAST PRICE5.1200
- TODAY'S CHANGE (%)0.0100 (0.1957%)
- Bid / Lots5.1100/ 25
- Ask / Lots5.1200/ 16
- Open / Previous Close5.0700 / 5.1100
- Day Range
- 52 Week Range
- Volume503,175
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VNDA |
|---|---|---|
| 09:32 ET | 22875 | 5.08 |
| 09:34 ET | 4709 | 5.055 |
| 09:36 ET | 2643 | 5.085 |
| 09:38 ET | 2207 | 5.09 |
| 09:39 ET | 850 | 5.11 |
| 09:41 ET | 1000 | 5.08 |
| 09:43 ET | 300 | 5.0992 |
| 09:45 ET | 4261 | 5.11 |
| 09:50 ET | 1618 | 5.1084 |
| 09:52 ET | 530 | 5.11 |
| 09:54 ET | 1879 | 5.13 |
| 09:56 ET | 944 | 5.125 |
| 09:57 ET | 1200 | 5.135 |
| 09:59 ET | 1200 | 5.13 |
| 10:01 ET | 2247 | 5.13 |
| 10:03 ET | 350 | 5.14 |
| 10:06 ET | 6149 | 5.1509 |
| 10:08 ET | 2910 | 5.155 |
| 10:10 ET | 5137 | 5.13 |
| 10:14 ET | 34019 | 5.15 |
| 10:15 ET | 1300 | 5.165 |
| 10:17 ET | 1200 | 5.17 |
| 10:19 ET | 3675 | 5.165 |
| 10:21 ET | 1600 | 5.16 |
| 10:24 ET | 200 | 5.17 |
| 10:26 ET | 100 | 5.175 |
| 10:28 ET | 500 | 5.19 |
| 10:30 ET | 2300 | 5.175 |
| 10:32 ET | 20895 | 5.155 |
| 10:33 ET | 9253 | 5.131 |
| 10:35 ET | 300 | 5.135 |
| 10:37 ET | 700 | 5.135 |
| 10:39 ET | 500 | 5.135 |
| 10:42 ET | 900 | 5.14 |
| 10:44 ET | 800 | 5.135 |
| 10:46 ET | 4499 | 5.13 |
| 10:48 ET | 1554 | 5.14 |
| 10:50 ET | 200 | 5.145 |
| 10:51 ET | 1361 | 5.145 |
| 10:53 ET | 590 | 5.1412 |
| 10:55 ET | 200 | 5.145 |
| 10:57 ET | 700 | 5.145 |
| 11:00 ET | 200 | 5.145 |
| 11:02 ET | 400 | 5.145 |
| 11:04 ET | 6950 | 5.12 |
| 11:06 ET | 1089 | 5.115 |
| 11:08 ET | 2112 | 5.1099 |
| 11:09 ET | 474 | 5.11 |
| 11:11 ET | 3400 | 5.105 |
| 11:13 ET | 1343 | 5.105 |
| 11:15 ET | 2423 | 5.095 |
| 11:18 ET | 300 | 5.105 |
| 11:22 ET | 400 | 5.1063 |
| 11:24 ET | 100 | 5.105 |
| 11:26 ET | 20761 | 5.12 |
| 11:27 ET | 200 | 5.12 |
| 11:29 ET | 947 | 5.12 |
| 11:31 ET | 100 | 5.11 |
| 11:33 ET | 700 | 5.105 |
| 11:36 ET | 100 | 5.105 |
| 11:38 ET | 12366 | 5.115 |
| 11:42 ET | 4800 | 5.12 |
| 11:44 ET | 15148 | 5.13 |
| 11:45 ET | 500 | 5.135 |
| 11:47 ET | 100 | 5.135 |
| 11:49 ET | 500 | 5.1314 |
| 11:51 ET | 1500 | 5.13 |
| 11:56 ET | 28673 | 5.12 |
| 11:58 ET | 1345 | 5.135 |
| 12:00 ET | 927 | 5.135 |
| 12:02 ET | 500 | 5.135 |
| 12:03 ET | 1000 | 5.1311 |
| 12:05 ET | 600 | 5.13 |
| 12:07 ET | 4444 | 5.13 |
| 12:09 ET | 100 | 5.135 |
| 12:12 ET | 400 | 5.13 |
| 12:23 ET | 100 | 5.135 |
| 12:25 ET | 100 | 5.135 |
| 12:27 ET | 100 | 5.135 |
| 12:30 ET | 100 | 5.135 |
| 12:32 ET | 100 | 5.135 |
| 12:34 ET | 600 | 5.135 |
| 12:36 ET | 200 | 5.135 |
| 12:38 ET | 100 | 5.135 |
| 12:39 ET | 650 | 5.14 |
| 12:41 ET | 1798 | 5.125 |
| 12:43 ET | 700 | 5.125 |
| 12:48 ET | 318 | 5.125 |
| 12:50 ET | 426 | 5.13 |
| 12:52 ET | 5399 | 5.14 |
| 12:54 ET | 400 | 5.145 |
| 12:56 ET | 2900 | 5.15 |
| 12:57 ET | 1000 | 5.145 |
| 12:59 ET | 4225 | 5.15 |
| 01:01 ET | 400 | 5.15 |
| 01:03 ET | 100 | 5.15 |
| 01:06 ET | 2100 | 5.1412 |
| 01:08 ET | 1882 | 5.15 |
| 01:10 ET | 300 | 5.155 |
| 01:12 ET | 3021 | 5.16 |
| 01:14 ET | 8189 | 5.17 |
| 01:15 ET | 2118 | 5.17 |
| 01:17 ET | 6400 | 5.175 |
| 01:19 ET | 500 | 5.175 |
| 01:21 ET | 1191 | 5.175 |
| 01:24 ET | 1000 | 5.175 |
| 01:26 ET | 9646 | 5.155 |
| 01:28 ET | 816 | 5.156 |
| 01:30 ET | 711 | 5.155 |
| 01:32 ET | 2348 | 5.155 |
| 01:33 ET | 1000 | 5.155 |
| 01:35 ET | 36103 | 5.1543 |
| 01:37 ET | 17648 | 5.135 |
| 01:39 ET | 808 | 5.135 |
| 01:42 ET | 600 | 5.135 |
| 01:44 ET | 1100 | 5.135 |
| 01:46 ET | 1347 | 5.1384 |
| 01:48 ET | 1231 | 5.135 |
| 01:50 ET | 3555 | 5.14 |
| 01:51 ET | 900 | 5.1412 |
| 01:53 ET | 200 | 5.145 |
| 01:55 ET | 650 | 5.15 |
| 01:57 ET | 3600 | 5.13 |
| 02:02 ET | 6068 | 5.1275 |
| 02:04 ET | 4460 | 5.105 |
| 02:06 ET | 3743 | 5.115 |
| 02:08 ET | 1824 | 5.115 |
| 02:09 ET | 300 | 5.115 |
| 02:13 ET | 3438 | 5.115 |
| 02:15 ET | 3931 | 5.115 |
| 02:18 ET | 300 | 5.12 |
| 02:20 ET | 100 | 5.12 |
| 02:22 ET | 6577 | 5.095 |
| 02:24 ET | 6113 | 5.1 |
| 02:26 ET | 100 | 5.1 |
| 02:27 ET | 2985 | 5.105 |
| 02:29 ET | 500 | 5.105 |
| 02:31 ET | 8671 | 5.095 |
| 02:36 ET | 155 | 5.096 |
| 02:38 ET | 300 | 5.0901 |
| 02:40 ET | 200 | 5.095 |
| 02:42 ET | 4595 | 5.095 |
| 02:45 ET | 3194 | 5.085 |
| 02:47 ET | 600 | 5.085 |
| 02:49 ET | 154 | 5.085 |
| 02:51 ET | 1547 | 5.095 |
| 02:54 ET | 6251 | 5.115 |
| 02:56 ET | 200 | 5.12 |
May 15, 2024
Vanda Pharmaceuticals Reports Positive Results from a Second Phase III Study of Tradipitant in Motion Sickness, from 8:45AM ET on Wednesday May 15, 2024 by Dow Jones
8:45AM ET on Wednesday May 15, 2024 by Dow Jones
May 8, 2024
*DJ Vanda Pharmaceuticals 1Q Loss/Shr 7c >VNDA, from 4:01PM ET on Wednesday May 08, 2024 by Dow Jones
4:01PM ET on Wednesday May 08, 2024 by Dow JonesVanda Pharmaceuticals Reports First Quarter 2024 Financial Results, from 4:01PM ET on Wednesday May 08, 2024 by Dow Jones
4:01PM ET on Wednesday May 08, 2024 by Dow Jones
May 7, 2024
DJ Vanda Pharmaceuticals Shares Rise After Future Pak Sweetens Bid, from 11:44AM ET on Tuesday May 07, 2024 by Dow Jones
11:44AM ET on Tuesday May 07, 2024 by Dow JonesVanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak, from 11:17AM ET on Tuesday May 07, 2024 by Dow Jones
11:17AM ET on Tuesday May 07, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vanda Pharmaceuticals Inc | 297.4M | -60.5x | -37.98% |
Akebia Therapeutics Inc | 236.8M | -5.1x | --- |
Anika Therapeutics Inc | 381.8M | -4.9x | --- |
Sangamo Therapeutics Inc | 124.0M | -0.3x | --- |
Revance Therapeutics Inc | 314.4M | -0.8x | --- |
Agenus Inc | 233.5M | -1.0x | --- |
Company Information
Vanda Pharmaceuticals Inc. is a biopharmaceutical company, which is focused on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The Company’s commercial portfolio is comprised of three products: HETLIOZ for the treatment of non-24-hour sleep-wake disorder (Non-24) and for the treatment of nighttime sleep disturbances in smith-magenis syndrome (SMS), Fanapt (iloperidone) for the treatment of bipolar I disorder and a long acting injectable (LAI) formulation for the treatment of schizophrenia, and PONVORY (ponesimod) for the treatment of inflammatory/autoimmune disorders, including ulcerative colitis, psoriasis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis and alopecia areata. The Company also has a range of drugs in development, including Tradipitant (VLY-686), VHX-896, VSJ-110, VPO-227, VTR-297, VQW-765, VCA-894A and Type 2S (CMT2S).
Contact Information
- Headquarters
- SUITE 300E, 2200 PENNSYLVANIA AVE NWWASHINGTON, DC, United States 20037
- Phone
- 202-734-3400
- Fax
- 202-296-1450
Executives
- Chairman of the Board, President, Chief Executive Officer
- Mihael Polymeropoulos
- Chief Financial Officer, Senior Vice President, Treasurer
- Kevin Moran
- Senior Vice President, Chief Marketing Officer
- Joakim Wijkstrom
- Senior Vice President, General Counsel, Secretary
- Timothy Williams
- Senior Vice President - Business Development
- Gunther Birznieks
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $297.4M |
|---|---|
Revenue (TTM) | $177.6M |
Shares Outstanding | 58.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.71 |
EPS | $-0.08 |
Book Value | $9.47 |
P/E Ratio | -60.5x |
Price/Sales (TTM) | 1.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -14.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
